Ultrastructure in Transthyretin Amyloidosis: From Pathophysiology to Therapeutic Insights
Transthyretin (TTR) amyloidosis is caused by systemic deposition of wild-type or variant amyloidogenic TTR (ATTRwt and ATTRv, respectively). ATTRwt amyloidosis has traditionally been termed senile systemic amyloidosis, while ATTRv amyloidosis has been called familial amyloid polyneuropathy. Although...
Main Authors: | Haruki Koike, Masahisa Katsuno |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-02-01
|
Series: | Biomedicines |
Subjects: | |
Online Access: | https://www.mdpi.com/2227-9059/7/1/11 |
Similar Items
-
Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies
by: Haruki Koike, et al.
Published: (2020-09-01) -
The Ultrastructure of Tissue Damage by Amyloid Fibrils
by: Haruki Koike, et al.
Published: (2021-07-01) -
Pathophysiology of Chronic Inflammatory Demyelinating Polyneuropathy: Insights into Classification and Therapeutic Strategy
by: Haruki Koike, et al.
Published: (2020-05-01) -
Macrophages and Autoantibodies in Demyelinating Diseases
by: Haruki Koike, et al.
Published: (2021-04-01) -
Successful Diflunisal Desensitization in a Transthyretin Amyloidosis Patient With Ibuprofen Allergy: A Case Report
by: Jialing Aw, et al.
Published: (2022-07-01)